AOM/DSS-treated mice showed an elevated expression of the chemokines CXCL1 and CXCL2, which induce neutrophil recruitment, whereas vancomycin treatment inhibited the expression of these chemokines (Fig. 6A). This evidence concerns the gene CXCL2 and infectious otitis media.